200 related articles for article (PubMed ID: 38499600)
1. Unveiling potential drug targets for hyperparathyroidism through genetic insights via Mendelian randomization and colocalization analyses.
Chen B; Wang L; Pu S; Guo L; Chai N; Sun X; Tang X; Ren Y; He J; Hao N
Sci Rep; 2024 Mar; 14(1):6435. PubMed ID: 38499600
[TBL] [Abstract][Full Text] [Related]
2. Mendelian randomization analysis identifies druggable genes and drugs repurposing for chronic obstructive pulmonary disease.
Wang Z; Li S; Cai G; Gao Y; Yang H; Li Y; Liang J; Zhang S; Hu J; Zheng J
Front Cell Infect Microbiol; 2024; 14():1386506. PubMed ID: 38660492
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic targets for endometriosis: Genome-wide Mendelian randomization and colocalization analyses.
Zeng P; Lu L; Zhang H; Li Y; Tan S; Yu T; Zhou H
Gene; 2024 Jan; 893():147970. PubMed ID: 37931855
[TBL] [Abstract][Full Text] [Related]
4. Genetic insights into therapeutic targets for aortic aneurysms: A Mendelian randomization study.
Chen Y; Xu X; Wang L; Li K; Sun Y; Xiao L; Dai J; Huang M; Wang Y; Wang DW
EBioMedicine; 2022 Sep; 83():104199. PubMed ID: 35952493
[TBL] [Abstract][Full Text] [Related]
5. Drug-target Mendelian randomization revealed a significant association of genetically proxied metformin effects with increased prostate cancer risk.
Sun X; Ping J; Guo X; Long J; Cai Q; Shu XO; Shu X
Mol Carcinog; 2024 May; 63(5):849-858. PubMed ID: 38517045
[TBL] [Abstract][Full Text] [Related]
6. Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes.
Yang C; Fagan AM; Perrin RJ; Rhinn H; Harari O; Cruchaga C
Genome Med; 2022 Dec; 14(1):140. PubMed ID: 36510323
[TBL] [Abstract][Full Text] [Related]
7. Mendelian randomization and colocalization analysis reveal novel drug targets for myasthenia gravis.
Ouyang Y; Chen Y; Chen K; Tang Z; Shi G; Qu C; Zhang K; Yang H
Hum Genomics; 2024 Apr; 18(1):43. PubMed ID: 38659056
[TBL] [Abstract][Full Text] [Related]
8. Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis.
Yarmolinsky J; Díez-Obrero V; Richardson TG; Pigeyre M; Sjaarda J; Paré G; Walker VM; Vincent EE; Tan VY; Obón-Santacana M; Albanes D; Hampe J; Gsur A; Hampel H; Pai RK; Jenkins M; Gallinger S; Casey G; Zheng W; Amos CI; ; ; ; Smith GD; Martin RM; Moreno V
PLoS Med; 2022 Feb; 19(2):e1003897. PubMed ID: 35113855
[TBL] [Abstract][Full Text] [Related]
9. Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma.
Zhang L; Xiong Y; Zhang J; Feng Y; Xu A
J Transl Med; 2024 Apr; 22(1):330. PubMed ID: 38576019
[TBL] [Abstract][Full Text] [Related]
10. Prioritizing putative influential genes in cardiovascular disease susceptibility by applying tissue-specific Mendelian randomization.
Taylor K; Davey Smith G; Relton CL; Gaunt TR; Richardson TG
Genome Med; 2019 Jan; 11(1):6. PubMed ID: 30704512
[TBL] [Abstract][Full Text] [Related]
11. Integrative multi-omics analysis identifies genetically supported druggable targets and immune cell specificity for myasthenia gravis.
Li J; Wang F; Li Z; Feng J; Men Y; Han J; Xia J; Zhang C; Han Y; Chen T; Zhao Y; Zhou S; Da Y; Chai G; Hao J
J Transl Med; 2024 Mar; 22(1):302. PubMed ID: 38521921
[TBL] [Abstract][Full Text] [Related]
12. Mendelian Randomization Using the Druggable Genome Reveals Genetically Supported Drug Targets for Psychiatric Disorders.
Li X; Shen A; Zhao Y; Xia J
Schizophr Bull; 2023 Sep; 49(5):1305-1315. PubMed ID: 37418754
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial related genome-wide Mendelian randomization identifies putatively causal genes for multiple cancer types.
Li Y; Sundquist K; Zhang N; Wang X; Sundquist J; Memon AA
EBioMedicine; 2023 Feb; 88():104432. PubMed ID: 36634566
[TBL] [Abstract][Full Text] [Related]
14. Genetic overlap analysis of endometriosis and asthma identifies shared loci implicating sex hormones and thyroid signalling pathways.
Adewuyi EO; Mehta D; ; ; Nyholt DR
Hum Reprod; 2022 Jan; 37(2):366-383. PubMed ID: 35472084
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analyses.
Chen J; Xu F; Ruan X; Sun J; Zhang Y; Zhang H; Zhao J; Zheng J; Larsson SC; Wang X; Li X; Yuan S
EBioMedicine; 2023 Mar; 89():104494. PubMed ID: 36857861
[TBL] [Abstract][Full Text] [Related]
16. Potential drug targets for tumors identified through Mendelian randomization analysis.
Song N; Shi P; Cui K; Zeng L; Wang Z; Di W; Li J; Fan Y; Li Z; Zhang J; Su W; Wang H
Sci Rep; 2024 May; 14(1):11370. PubMed ID: 38762700
[TBL] [Abstract][Full Text] [Related]
17. Identifying drug targets for neurological and psychiatric disease via genetics and the brain transcriptome.
Baird DA; Liu JZ; Zheng J; Sieberts SK; Perumal T; Elsworth B; Richardson TG; Chen CY; Carrasquillo MM; Allen M; Reddy JS; De Jager PL; Ertekin-Taner N; Mangravite LM; Logsdon B; Estrada K; Haycock PC; Hemani G; Runz H; Smith GD; Gaunt TR;
PLoS Genet; 2021 Jan; 17(1):e1009224. PubMed ID: 33417599
[TBL] [Abstract][Full Text] [Related]
18. Dissecting the shared genetic landscape of anxiety, depression, and schizophrenia.
Tao Y; Zhao R; Yang B; Han J; Li Y
J Transl Med; 2024 Apr; 22(1):373. PubMed ID: 38637810
[TBL] [Abstract][Full Text] [Related]
19. Mendelian Randomization Study Using Dopaminergic Neuron-Specific eQTL Identifies Novel Risk Genes for Schizophrenia.
Dang X; Liu J; Zhang Z; Luo XJ
Mol Neurobiol; 2023 Mar; 60(3):1537-1546. PubMed ID: 36517655
[TBL] [Abstract][Full Text] [Related]
20. Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study.
Fang S; Yarmolinsky J; Gill D; Bull CJ; Perks CM; ; Davey Smith G; Gaunt TR; Richardson TG
PLoS Med; 2023 Jan; 20(1):e1003988. PubMed ID: 36595504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]